You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

203 Results
Blog posts

Blog Category: Our Partners and the System

For many of us, birthdays mean scrumptious cake, glowing candles, gifts and greeting cards. If you’ve just turned 50, those birthday greetings will...
Mar 2018
Document
Mar 2018
Document
Mar 2018
Document
Jun 2018
Document
Jun 2018
Drug
Other Name(s): Alunbrig®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jul 2024
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    brigatinib - For the treatment of anaplastic lymphoma kinase-positive locally advanced or metastatic non-small cell lung cancer according to clinical criteria
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
brigatinib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jul 2024
Regimen
Cancer Type:
Lung, 
Mesothelioma (Pleural)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
bevacizumab (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Oct 2024
Blog posts

Blog Category: Our Partners and the System

Recently, I provided opening remarks at an event that brought together various stakeholders to discuss opportunities and challenges presented by the...
Dec 2018
Blog posts

Blog Category: Insights & Perspectives

This past spring I was giving a talk about the My CancerIQ risk assessment tool at one of Ontario’s largest primary care conferences. And, as I so...
Jan 2019
Guidelines and Advice
Status: In-Review
ID: RR 21-5
Version: n/a
Jan 2019
Blog posts

Blog Category: Our Partners and the System

Anyone who has lived with a diagnosis of cancer or has supported a loved one through treatment knows the toll that the illness can carry. Travelling...
Apr 2019

Pages